Newsletter sign up


ADC University Our services

ADC Review
is made possible by:



Copyright 2017
Terms & Conditions


Antibody Drug Conjugates Seminar

  • All day: April 20, 2016
  • City/Town: London, United Kingdom
  • Location: London
  • Event Type: Industry Medical Scientific
  • Website: Go to website
  • Phone: +44 (0)1865 248 455
  • e-Mail: info@oxfordglobal.co.uk
  • Organized by: Oxford Global Training

Published on 02nd March

OXFORD_Global_adcreview_ADC_725x95Seminar

Topics to be Covered

  • Introduction To Antibody Conjugates
  • Overview Of Techniques In Quantitative Pharmacology
  • No Such Thing As A Magic Bullet: The Hidden Challenges Of ADC Discovery And Development
  • Case Studies Of Design Decisions In ADC Discovery And Development

Benefits to Attending

  • Gain a comprehensive overview of the ADC industry and an insight into the current trends in ADC development
  • Fully understand the mechanism by which ADCs function and relate this back to your design parameters
  • Have a broad understanding of different strategies for ADC production and consider the optimal choice for your company
  • Explore options for site-specific conjugations and learn about current research into more potent cytotoxic payloads
  • Identify the most important new technologies driving innovation in the field, and consider the application of these technologies in your own research
  • Maximise the therapeutic impact of your ADCs; compare conjugation strategies, linker technology and payload engineering to enhance cytotoxicity
  • Achieve a deeper understanding of ADCs through real-life case studies and discussions based on real-world scenarios

Who Should Attend?
OXFORD_Global_ADC_300x300seminarParticipants will be professionals in the antibody industry who are looking to gain a more detailed insight into this exciting field of research.

Participants will have experience of antibody engineering and development but will not necessarily be experts in ADCs. They will be looking to learn more about ADCs; their design, development, challenges and regulatory expectations.

Seminar Trainer
Arijit Chakravarty, Director, Modeling and Simulation, Takeda Pharmaceuticals Int. Co.


Last Editorial Review: March 2, 2016

Photo: London, Tower Bridge. Photo courtesey: © Robert Pittman. Used with Permission.

Copyright © 2016 InPress Media Group. All rights reserved. Republication or redistribution of InPress Media Group content, including by framing or similar means, is expressly prohibited without the prior written consent of InPress Media Group. InPress Media Group shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. ADC Review / Journal of Antibody-drug Conjugates is a registered trademarks and trademarks of InPress Media Group around the world.

Add to Flipboard Magazine.


Print Friendly, PDF & Email

Share

Facebook share Twitter share Linkedin share Google Plus share

Featured Event

Topics to be Covered Introduction To Antibody Conjugates Overview Of Techniques In Quantitative Pharmacology No Such Thing As A Magic Bullet: The Hidden Challenges Of ADC Discovery And Development...


Skip to toolbar